BMO Gives Cameco Price Target A Lift To $33

On February 9th, Cameco (TSX: CCO) reported its full-year 2021 financial results. The company reported full-year revenues of $1.47 billion, down 18% from 2020. Gross profits came in at $1.93 million, down from $106.45 million last year, or down 98.2%. The company saw a negative operating profit of -$132.41 million, and reported a net income of -$102.58 million or an earnings per share of -$0.26.

The company noted that the company’s operations have been interrupted by COVID, with a 4-month suspension at Cigar Lake taking place as a precaution, which only produced 6.1 million pounds below their committed sales. They also saw a $40 million care and maintenance cost due to this closure.

Cameco currently has 14 analysts covering the stock with an average 12-month price target of C$36.91, or a 30% upside to the current stock price. Out of the 14 analysts, 4 have strong buy ratings, 7 have buy ratings and the other 3 analysts have hold ratings. The street high sits at C$40.50, which represents a 42% upside to the current stock price and the lowest 12-month price target comes in at C$30.

In BMO Capital Markets’ note, they reiterate their market performance rating and raised their 12-month price target from C$32 to C$33, saying that Cameco signing an additional 40mlb of contracts “is clearly positive to the market sentiment.”

They add, “there are a number of reasons to get more constructive on Cameco,” which includes the restarting of its McArthur River mine. Even with the mine restarting, BMO says that their 2023/2024 production estimates are roughly 4mlb lower than previous. The initial rate for McArthur River is capped at 15 mlb versus their 18 mlb expected previously. This puts BMO’s attributable production to 21.3mlb for 2023/2024.

Below you can see BMO’s updated full-year 2022 and 2023 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Eldorado Gold: The $3.8 Billion Foran Mining Acquisition

Silver Tiger’s $2.35B Silver Blueprint: Two Mines, One Perfect Metals Market

Gold Is At Records. Barrick Mining Is Printing Cash. The Stock Still Fell. | Q4 Earnings

Recommended

Goliath Resources Sees 13% Grade Boost As Stifel Draws Parallels To Great Bear

First Majestic Q4 2025: Record Revenue, Earnings, Annual Silver Output

Related News

Organigram: Haywood Raises Estimates Betting On Increased Market Share

On January 11th, Organigram Holdings (TSX: OGI) issued its second fiscal quarter earnings for 2022....

Saturday, January 15, 2022, 11:09:00 AM

Medmen: Canaccord Drops Price Target To $0.35 After Q1 Results

On November 9th, Medmen Enterprises (CSE: MMEN) reported their fiscal first-quarter financial results. The company...

Sunday, November 14, 2021, 10:03:00 AM

Ayr Strategies Price Target Upgraded By Canaccord, Echelon Wealth Following Second Quarter Reporting

Last week, Ayr Strategies (CSE: AYR.A) reported their second-quarter financials and reached an agreement to...

Saturday, August 29, 2020, 01:39:00 PM

Curaleaf: Consensus Estimate Falls To $20.18 After Weak Guidance

On March 3rd, Curaleaf Holdings, Inc. (CSE: CURA) reported its fourth quarter and full year...

Friday, March 11, 2022, 04:20:00 PM

Cresco Labs: Cantor Lowers Price Target To $12.65

On September 3, Cresco Labs (CSE: CL) announced that they closed their acquisition of Cultivate,...

Thursday, September 16, 2021, 03:37:00 PM